Advances of miRNAs in kidney graft injury
Jiyue Wu1, Feilong Zhang1, Jiandong Zhang1
1Institute of Urology, Beijing Chaoyang Hospital, Capital Medical Unversity, China.
Abstract:
Kidney transplantation is the preferred treatment for patients with end-stage renal disease. However, various types of kidney graft injury after transplantation are still key factors that affect the survival of the kidney graft. Therefore, exploring the underlying mechanisms involved is very important. Current diagnostic measures for kidney graft injury (including needle biopsy, blood creatinine, eGFR, etc.) have many limiting factors such as invasiveness, insufficient sensitivity and specificity, so they cannot provide timely and effective information to clinicians. As for kidney grafts that have occurred injury, the traditional treatment has a little efficacy and many side effects. Therefore, there is an urgent need for developing new biomarkers and targeted treatment for kidney graft injury. Recently, studies have found that miRNAs are involved in the regulation of the progression of kidney graft injury. At the same time, it has high stability in blood, urine, and other body fluids, so it is suggested to have the potential as a biomarker and therapeutic target for kidney graft injury. Here, we reviewed the miRNAs involved in the pathophysiology of kidney graft injury such as ischemia/reperfusion injury, acute rejection, drug-induced nephrotoxicity, chronic allograft dysfunction, BK virus infection, and the latest advances of miRNAs as biomarkers and therapeutic targets of kidney graft injury, then summarized the specific data of miRNAs expression level in kidney graft injury, which aims to provide a reference for subsequent basic research and clinical transformation.
Insights
MicroRNAs (miRNAs) show promise as biomarkers and therapeutic targets for kidney graft injury, offering a stable and accessible option beyond current diagnostic limitations. This review explores their role in various kidney injury types and their potential for clinical application.
Area of Science:
- Nephrology
- Molecular Biology
- Transplantation Immunology
Background:
- Kidney graft injury significantly impacts graft survival post-transplantation for end-stage renal disease patients.
- Current diagnostic methods for kidney graft injury, like biopsy and creatinine levels, have limitations including invasiveness and low sensitivity/specificity.
- There is a critical need for novel biomarkers and effective treatments for kidney graft injury.
Purpose of the Study:
- To review the role of microRNAs (miRNAs) in the pathophysiology of various kidney graft injuries.
- To explore the potential of miRNAs as diagnostic biomarkers and therapeutic targets for kidney graft injury.
- To summarize miRNA expression data in kidney graft injury for future research and clinical translation.
Main Methods:
- Literature review of studies investigating miRNAs in kidney graft injury.
- Analysis of miRNA involvement in specific injury types: ischemia/reperfusion injury, acute rejection, drug-induced nephrotoxicity, chronic allograft dysfunction, and BK virus infection.
- Compilation of data on miRNA expression levels in kidney graft injury.
Main Results:
- MicroRNAs are implicated in regulating the progression of kidney graft injury.
- miRNAs exhibit high stability in body fluids, suggesting potential as non-invasive biomarkers.
- Specific miRNA expression patterns are associated with different types of kidney graft injury.
Conclusions:
- MicroRNAs represent promising biomarkers for early and accurate detection of kidney graft injury.
- miRNAs hold potential as novel therapeutic targets to mitigate kidney graft injury and improve graft survival.
- Further research into miRNA mechanisms and clinical validation is warranted for effective translation.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure


